Form 8-K - Current report:
SEC Accession No. 0001104659-25-061230
Filing Date
2025-06-20
Accepted
2025-06-20 17:20:52
Documents
13
Period of Report
2025-06-16
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2518572d1_8k.htm   iXBRL 8-K 29499
2 EXHIBIT 99.1 tm2518572d1_ex99-1.htm EX-99.1 159480
  Complete submission text file 0001104659-25-061230.txt   363630

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ptpi-20250616.xsd EX-101.SCH 3026
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE ptpi-20250616_lab.xml EX-101.LAB 34239
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ptpi-20250616_pre.xml EX-101.PRE 22366
15 EXTRACTED XBRL INSTANCE DOCUMENT tm2518572d1_8k_htm.xml XML 3812
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005
Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)

EIN.: 851410058 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39752 | Film No.: 251062367
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)